ReCode Therapeutics @ReCodeTx

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. recodetx.com Menlo Park, CA & Dallas, TX Joined October 2020

Tweets

171
Followers

544
Following

157
Likes

23

ReCode Therapeutics @ReCodeTx

3 years ago

Better delivery platforms can unleash the true potential of genetic medicines. These must deliver drugs beyond the liver – to the lungs, spleen, and beyond. Learn how we are powering the next wave of genetic medicines through superior delivery: recodetx.com

0 0 3 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

We’re at the @mrnaconference this week. Come join our session at 3:10pm ET where David Lockhart, our President and CSO, will be talking about our SORT LNP-formulated mRNA for the treatment of #PrimaryCiliaryDyskinesia.

0 1 7 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

On this week’s episode of The Long Run podcast, our CEO @SulimanShehnaaz had the opportunity to speak with @ldtimmerman about her #leadership journey, our strategy and vision, and how we're improving the delivery of #geneticmedicine. Take a listen! bit.ly/3NLHmtj

0 1 2 0 0

ReCode Therapeutics @ReCodeTx

3 years ago

We want to say thank you to everyone who participated in the #NACFC2022 conference this year. We’re truly inspired by the passionate people we met who are carrying forward research to treat the thousands of people living with #CysticFibrosis.

0 1 3 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

This month, we’ll be participating in the @CreditSuisse and @Stifel Healthcare Conferences. We’re looking forward to sharing more about our novel #genetic #medicines delivery platform and pipeline of disease-modifying #mRNA & gene correction therapeutics. recodetx.com/recode-therape…

0 0 0 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

We’re excited to attend #NACFC2022 this year with other members of the #CysticFibrosis community. Please visit us at booth #1020 to learn more about our investigational therapy for CF patients who have nonsense mutations & do not respond to currently approved CFTR modulators.

0 2 3 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

We’re very proud to have been nominated for the 2022 #PrixGalien award for “Best Startup in the Pharmaceutical or Biotechnology Industry.” Thank you @GalienFdn for this honor and congratulations to all of this year’s winners and nominees for your work to improve human health!

0 2 3 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

This #LungHealthDay, we recognize the importance of #LungHealth and show support to those living with a rare lung condition. At Recode, we aim to improve the lives of these patients by developing genetic medicines with superior delivery. Learn more at recodetx.com/pipeline/

0 1 2 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

Will we see you at #PODD2022 in Boston next week? On Monday, our director of BD Ariel Kantor will talk about how our novel SORT LNP platform is overcoming the limitations of conventional LNPs to enable superior delivery of #RNA and next-gen gene correction therapeutics

0 1 2 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

#PrimaryCiliaryDyskinesia, or #PCD, is challenging to diagnose leading to both missed diagnosis and misdiagnosis. Although there is no treatment for PCD, an early diagnosis can help protect and delay damage to the lungs. Source: nhlbi.nih.gov/health/primary…. #PCDAwarenessMonth

1 4 7 0 1

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

#CysticFibrosis (CF) can make it very difficult to breathe. This #HealthyLungMonth, we’re raising awareness about this disease and the way in which it affects the lungs. Learn more about CF and our approach to a CFTR mRNA therapy at recodetx.com/pipeline/.

0 0 1 0 0

Download Image

ReCode Therapeutics @ReCodeTx

3 years ago

This week at EMBO #Cilia2022 in Cologne, our own Mirko Hennig, presented important preclinical data that showed our investigational inhaled DNAI1 mRNA treatment for #PCD has low immune reactivity, rescues ciliary function & results in long-lasting functional recovery.